Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio Pricing

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Mineralys Therapeutics, Inc. (MLYS) Financials - StockMarketCap

Stocks›Mineralys Therapeutics, Inc.☆

● FreshLatest: Jul 6, 2026

Mineralys Therapeutics, Inc.

MLYS✓

HealthcareBiotechnologyNASDAQ

$29.47+6.43%

$1.95BMarket cap

-P/E ratio

1.21MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$29.47

$1.78 (+6.43%) · 24h

Key metrics

Market cap$1.95B+28.78%

Enterprise value$1.95B

Volume (24h)1.21M

P/E ratio (TTM)-

P/S ratio (TTM)-

Dividend yield-

Shares outstanding66.30M

Trading range

Previous close$27.69

Day range$27.01 - $29.90

52-week range-

Mineralys Therapeutics, Inc. (MLYS) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company-0.66%

Johnson & Johnson-1.38%

AbbVie Inc.-2.38%

UnitedHealth Group Incorporated-2.16%

Roche Holding AG-2.58%

Merck & Co., Inc.-2.19%

Financial statements coming soon for Mineralys Therapeutics, Inc..